Delisting riskPopularity #4,224
Filana Therapeutics (FLNA)
Developing simufilam, an oral small molecule, for TSC-related epilepsy.
$0.9803
After hours−0.05 (−4.83%)
At close$1.03(+39.28%)
Something off on this page? Send us feedback.
Next report
Oct 29, 26
in 37 days
EPS estimate
−$0.25
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Jul '26Oct '26
Reported−$0.57−$0.48−$0.92−$0.22−$0.26−$0.21−$0.18Pending
Estimate−$0.58——−$0.27−$0.30−$0.23−$0.23−$0.25
Surprise+2.3%——+18.5%+13.3%+8.7%+20.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Jul '26Oct '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.29 | — | — |
| Sep 2027 | −$0.32 | — | — |
| Jun 2027 | −$0.30 | — | — |
| Mar 2027 | −$0.28 | — | — |
| Dec 2026 | −$0.27 | — | — |
| Oct 2026 | −$0.25 | — | — |
| Jul 2026 | −$0.23 | −$0.18 | +20.0% |
| May 2026 | −$0.23 | −$0.21 | +8.7% |
| Mar 2026 | −$0.30 | −$0.26 | +13.3% |
| Nov 2025 | −$0.27 | −$0.22 | +18.5% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.29 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.32 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.30 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.28 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.27 | — | — | $0 | — | — | — |
| Oct 29, 2026 | −$0.25 | — | — | $0 | — | — | — |
| Jul 29, 2026 | −$0.23 | −$0.18 | +20.0% | — | — | — | −1.7% |
| May 7, 2026 | −$0.23 | −$0.21 | +8.7% | — | — | — | −5.6% |
| Mar 12, 2026 | −$0.30 | −$0.26 | +13.3% | — | — | — | −6.7% |
| Nov 12, 2025 | −$0.27 | −$0.22 | +18.5% | — | — | — | — |
| Aug 14, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 3, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 10, 2024 |